Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Debra Ainge

Brain cancer glioblastoma

Glioblastoma market set for ‘meteoric rise’

Sales of treatments for rare brain cancer predicted to reach $3.3bn by 2024

- PMLiVE

GSK appoints rare diseases research head

Birgitte Volck moves to the company from Swedish Ophan Biovitrum

Boyds appoints Dr Nick Meyers and Natasha Nesterova-Smith

Pharma and biotech consultancy company expands its senior team

How Bayer transformed its approach to digital

Head of digital development Jessica Federer on how the company built digital into its DNA

- PMLiVE

FDA panel backs approval of first opioid addiction implant

Probuphine has been developed by Titan Pharma and partner Braeburn Pharma

- PMLiVE

Robert Califf moves a step closer to FDA leadership

US Senate committee backs his nomination to serve as the regulator's commissioner

Novartis sets sights on connected inhaler

Plans 2019 launch for Qualcomm-partnered device

- PMLiVE

Dr Harley Simon moves from Merck & Co to ClinTec

Appointed chief medical office and EVP, client relations at the CRO

- PMLiVE

Merck & Co buys IOmet to boost immuno-oncology tech

Reports suggest it paid up to £280m for the Scottish biopharma company

Roche Basel Switzerland

AbbVie and Roche hoping for speedy venetoclax approval

Leukaemia treatment could reach US and EU markets within months

- PMLiVE

Celgene makes changes to its senior leadership team

Bob Hugin, Mark Alles, Jacqualyn Fouse and Scott Smith take on new roles

- PMLiVE

AbbVie takes ‘one-size-fits-all’ HCV regimen into phase III

Comes shortly after Gilead wins priority FDA review for its 'pan-genotypic' treatment

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links